MGMT and glioblastoma: Similarly, another research group used brain MRI images from a different cohort of GBM patients to build a bidirectional convolutional recurrent NN (CRNN) model to predict methylation status of MGMT gene promoter and suggested patient’s sensitivity to temozolomide based on the prediction of methylation status [82].